Exhaled nitric oxide during acute changes of airways calibre in asthma
Authors:
- I FajacIFI Fajac
- Jf DessangesJDJf Dessanges
- J Dall'AVa-SantucciJDJ Dall'AVa-Santucci
- A LockhartALA Lockhart
- At Dinh-XuanAt Dinh-Xuan
Open Access
- 1 June 1996
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 9 (6) , 1134-1138
Abstract
It has been shown that endogenous nitric oxide (NO), measured in exhaled air, is increased in asthmatic subjects and after allergen challenge in sensitized animals. NO is also a paracrine molecule with some, though weak, bronchodilator effects. However, whether the amount of endogenous NO that originates in the lungs can reflect the degree of bronchial tone and airways calibre in asthmatic subjects has not yet been investigated. The aim of this study was, therefore, to determine whether NO production could be modified by acute changes of airways calibre in mild, nonatopic, asthmatic subjects. NO output was measured in the exhaled air of 14 steroid-free asthmatics, 8 steroid-treated asthmatics and 21 control subjects. In seven steroid-free asthmatics, exhaled NO was measured after methacholine challenge, and then after salbutamol-induced bronchial dilatation. Exhaled tidal breathing was collected for 30 s and NO in the exhaled air was measured with a chemiluminescence analyser. Both NO concentration and its output were significantly higher in the steroid-free asthmatic patients (15.6 +/- 1.5 parts per billion (ppb) and 6.3 +/- 0.7 nmol.min-1, respectively) as compared with the control subjects (8.9 +/- 1.0 ppb and 3.5 +/- 0.3 nmol.min-1, respectively; p < 0.001 for both) and with the steroid-treated asthmatic patients (11.3 +/- 3.3 ppb and 3.7 +/- 0.9 nmol.min-1, respectively; p < 0.05 for both). Neither methacholine-induced bronchial obstruction nor salbutamol-induced bronchial dilatation caused a significant change in exhaled NO. We conclude that NO production is higher in steroid-free than in steroid-treated asthmatics and in control subjects. Furthermore, NO production is not affected by acute pharmacologically-induced changes of airways calibre in asthmatic subjects. Our results suggest that NO production is a marker of airways inflammation rather than an endogenous modulator of bronchial tone in asthma.Keywords
This publication has 39 references indexed in Scilit:
- Increased nitric oxide in exhaled air of asthmatic patientsThe Lancet, 1994
- Bovine bronchial epithelial cells metabolize L-arginine to L-citrulline: Possible role of nitric oxide synthaseLife Sciences, 1993
- Induction of nitric oxide synthase in asthmaThe Lancet, 1993
- Endogenous nitric oxide counteracts antigen-induced bronchoconstrictionEuropean Journal of Pharmacology, 1993
- Cytokines in symptomatic asthma airwaysJournal of Allergy and Clinical Immunology, 1992
- Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in humansEuropean Journal of Pharmacology, 1992
- Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humansBiochemical and Biophysical Research Communications, 1991
- L-Arginine-dependent production of nitrogen oxides by rat pulmonary macrophagesEuropean Journal of Pharmacology, 1991
- Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the ratBiochemical and Biophysical Research Communications, 1990
- Generation of nitric oxide by human neutrophilsBiochemical and Biophysical Research Communications, 1989